SAN DIEGO, June 6, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, inclusive (the "Class Period"), have until July 28, 2025 to seek...
Hence then, the article about urgn investor deadline urogen pharma ltd investors with substantial losses have opportunity to lead class action lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( URGN INVESTOR DEADLINE: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit )
Also on site :
- Nicolas Cage's 'Spider-Noir' Premieres May 27 With Dual-Format Viewing - Check Out the Official Trailer!
- Why Princess Diana Sent William and Harry to Boarding School at 8, Despite Being 'In Tears'
- 'Quite an evening': Trump wanted 'the show to go on' after shooting at White House Correspondents' Dinner